Influence of CCR5 and CCR2 Genetic Variants in the Resistance/Susceptibility to HIV in Serodiscordant Couples from Colombia

被引:0
|
作者
Zapata, Wildeman [1 ]
Aguilar-Jimenez, Wbeimar [1 ]
Pineda-Trujillo, Nicolas [2 ]
Rojas, Winston [3 ]
Estrada, Hernando [4 ]
Rugeles, Maria T. [1 ]
机构
[1] Univ Antioquia, Grp Inmunovirol, Fac Med, Medellin 1226, Colombia
[2] Univ Antioquia, Fac Med, Medellin 1226, Colombia
[3] Univ Antioquia, Inst Biol, Medellin 1226, Colombia
[4] HERES Salud LTDA, Santa Marta, Colombia
关键词
IMMUNODEFICIENCY-VIRUS TYPE-1; RECEPTOR; 5; GENE; DISEASE PROGRESSION; SERONEGATIVE INDIVIDUALS; MESSENGER-RNA; INFECTION; TRANSMISSION; PROMOTER; POPULATION; POLYMORPHISM;
D O I
10.1089/aid.2012.0299
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The main genetic factor related to HIV-1 resistance is the CCR5-32 mutation; however, the homozygous genotype is uncommon. The CCR5-32 mutation along with single nucleotide polymorphisms (SNPs) in the CCR5 promoter and the CCR2-V64I mutation have been included in seven human haplogroups (HH) previously associated with resistance/susceptibility to HIV-1 infection and different rates of AIDS progression. Here, we determined the association of the CCR5 promoter SNPs, the CCR5-32 mutation, CCR2-V64I SNP, and HH frequencies with resistance/susceptibility to HIV-1 infection in a cohort of HIV-1-serodiscordant couples from Colombia. Seventy HIV-1-exposed, but seronegative (HESN) individuals, 57 seropositives (SP), and 112 healthy controls (HC) were included. The CCR5-32 mutation and CCR2-V64I SNP were identified by PCR, and the CCR5 promoter SNPs were evaluated by sequencing. None of the individuals exhibited a homozygous 32 genotype; the CCR2-I allele was more frequent in HESN (34%) than HC (23%) (p=0.039, OR=1.672). The frequency of the 29G allele was higher in SP than HC (p=0.003, OR=3). HHF2 showed a higher frequency in HC (19%) than SP (9%) (p=0.027), while HHG1 was more frequent in SP (11.1%) than in HC (4.2%) (p=0.019). The AGACCAC-CCR2-I-CCR5 wild-type haplotype showed a higher frequency in SP (14.2%) than in HC (3.7%) (p=0.001). In conclusion, the CCR5-32 allele is not responsible for HIV-1 resistance in this HESN group; however, the CCR2-I allele could be protective, while the 29G allele might increase the likelihood of acquiring HIV-1 infection. HHG1 and the AGACCAC-CCR2-I-CCR5 wild-type haplotype might promote HIV-1 infection while HHF2 might be related to resistance. However, additional studies are required to evaluate the implications of these findings.
引用
收藏
页码:1594 / 1603
页数:10
相关论文
共 50 条
  • [1] Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression
    Smith, MW
    Dean, M
    Carrington, M
    Winkler, C
    Huttley, GA
    Lomb, DA
    Goedert, JJ
    OBrien, TR
    Jacobson, LP
    Kaslow, R
    Buchbinder, S
    Vittinghoff, E
    Vlahov, D
    Hoots, K
    Hilgartner, MW
    OBrien, SJ
    [J]. SCIENCE, 1997, 277 (5328) : 959 - 965
  • [2] Influence of CCR2 and CCR5 receptor genetic variants on HIV-1 infection and disease progression.
    Smith, MW
    Dean, M
    Carrington, M
    Winkler, C
    Huttley, GA
    Lomb, DA
    Goedert, JJ
    O'Brien, TR
    Jacobson, LP
    Kaslow, R
    Buchbinder, S
    Vittinghoff, E
    Vlahov, D
    Hoots, K
    Hilgartner, MW
    O'Brien, SJ
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A45 - A45
  • [3] CCR2 and CCR5 gene polymorphisms and susceptibility to sarcoidosis.
    Wischmeijer, TA
    Bombieri, C
    Agostini, C
    Semenzato, GP
    Luisetti, M
    Pignatti, PF
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) : 485 - 485
  • [4] Genetic variation at the chemokine receptors CCR5/CCR2 in myocardial infarction
    González, P
    Alvarez, R
    Batalla, A
    Reguero, JR
    Alvarez, V
    Astudillo, A
    Cubero, GI
    Cortina, A
    Coto, E
    [J]. GENES AND IMMUNITY, 2001, 2 (04) : 191 - 195
  • [5] Genetic variation at the chemokine receptors CCR5/CCR2 in myocardial infarction
    P González
    R Alvarez
    A Batalla
    JR Reguero
    V Alvarez
    A Astudillo
    GI Cubero
    A Cortina
    E Coto
    [J]. Genes & Immunity, 2001, 2 : 191 - 195
  • [6] Prevalence of CCR5 and CCR2 HIV-coreceptor gene polymorphisms in Belgium
    Struyf, F
    Thoelen, I
    Charlier, N
    Keyaerts, E
    Van der Donck, I
    Wuu, J
    Van Ranst, M
    [J]. HUMAN HEREDITY, 2000, 50 (05) : 304 - 307
  • [7] Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5
    Ogilvie, P
    Bardi, G
    Clark-Lewis, I
    Baggiolini, M
    Uguccioni, M
    [J]. BLOOD, 2001, 97 (07) : 1920 - 1924
  • [8] CCR5 and CCR2 gene polymorphisms in hypertensive patients
    Mettimano, M
    Specchia, ML
    Ianni, A
    Arzani, D
    Ricciardi, G
    Savi, L
    Romano-Spica, V
    [J]. BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 2003, 60 (01) : 19 - 21
  • [9] Influence of nucleotide polymorphisms in the CCR2 gene and the CCR5 promoter on the expression of cell surface CCR5 and CXCR4
    Shieh, B
    Liau, YE
    Hsieh, PS
    Yan, YP
    Wang, ST
    Li, C
    [J]. INTERNATIONAL IMMUNOLOGY, 2000, 12 (09) : 1311 - 1318
  • [10] Concerted evolution of vertebrate CCR2 and CCR5 genes and the origin of a recombinant equine CCR5/2 gene
    Perelygin, Andrey A.
    Zharkikh, Andrey A.
    Astakhova, Natalia M.
    Lear, Teri L.
    Brinton, Margo A.
    [J]. JOURNAL OF HEREDITY, 2008, 99 (05) : 500 - 511